Medsir
Clinical trials sponsored by Medsir, explained in plain language.
-
New approach aims to make tough cancer treatment more bearable
Disease control CompletedThis study tested whether giving two preventive medications (loperamide for diarrhea and G-CSF for low white blood cells) alongside the cancer drug sacituzumab govitecan could reduce its common and severe side effects. It involved 50 adults with advanced triple-negative or lumina…
Phase: PHASE2 • Sponsor: MedSIR • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New hope for aggressive breast cancer: drug combo trial shows promise
Disease control CompletedThis study compared two treatment approaches for people with advanced, aggressive breast cancer that has spread and cannot be removed by surgery. One group received a newer targeted pill (abemaciclib) plus standard hormone therapy. The other group started with a short course of c…
Phase: PHASE2 • Sponsor: MedSIR • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New hope for rare cancer: drug duo tested after chemo fails
Disease control CompletedThis study tested whether combining two existing cancer drugs, pembrolizumab and lenvatinib, could help control advanced thymic cancer that had worsened after standard chemotherapy. It enrolled 43 adults whose cancer could not be cured by surgery or radiation. The main goal was t…
Phase: PHASE2 • Sponsor: MedSIR • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC